Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Reduced Phosphodiesterase 3 Activity and Phosphodiesterase 3A Level in Synthetic Vascular Smooth Muscle Cells: Implications for Use of Phosphodiesterase 3 Inhibitors in Cardiovascular Tissues

Heather A. Dunkerley, Douglas G. Tilley, Daniel Palmer, Hanguan Liu, Sandra L. Jimmo and Donald H. Maurice
Molecular Pharmacology May 2002, 61 (5) 1033-1040; DOI: https://doi.org/10.1124/mol.61.5.1033
Heather A. Dunkerley
Department of Pharmacology and Toxicology, Queen's University at Kingston, Kingston, Ontario, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Douglas G. Tilley
Department of Pharmacology and Toxicology, Queen's University at Kingston, Kingston, Ontario, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel Palmer
Department of Pharmacology and Toxicology, Queen's University at Kingston, Kingston, Ontario, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hanguan Liu
Department of Pharmacology and Toxicology, Queen's University at Kingston, Kingston, Ontario, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sandra L. Jimmo
Department of Pharmacology and Toxicology, Queen's University at Kingston, Kingston, Ontario, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Donald H. Maurice
Department of Pharmacology and Toxicology, Queen's University at Kingston, Kingston, Ontario, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 61 no. 5 1033-1040
DOI 
https://doi.org/10.1124/mol.61.5.1033
PubMed 
11961121

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0026-895X
Online ISSN 
1521-0111
History 
  • Received November 6, 2001
  • Accepted February 7, 2002
  • Published online May 1, 2002.

Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Heather A. Dunkerley,
  2. Douglas G. Tilley,
  3. Daniel Palmer,
  4. Hanguan Liu,
  5. Sandra L. Jimmo, and
  6. Donald H. Maurice
  1. Department of Pharmacology and Toxicology, Queen's University at Kingston, Kingston, Ontario, Canada
  1. Dr. D. H. Maurice, Department of Pharmacology and Toxicology, Botterell Hall, A221, Queen's University at Kingston, Kingston, Ontario, Canada, K7L 3N6. E-mail: mauriced{at}post.queensu.ca
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: April 2002 to May 2023

AbstractFullPdf
Apr 2002363426
May 2002125331
Jun 200243320
Jul 200213323
Aug 20025177
Sep 200242112
Oct 20023227
Nov 20026164
Dec 20022118
Jan 200322426
Feb 20030824
Mar 20033104
Apr 200321727
May 200301312
Jun 20032158
Jul 2003103519
Aug 200372313
Sep 2003122815
Oct 200393019
Nov 2003183711
Dec 20037247
Jan 200482611
Feb 200472914
Mar 200483812
Apr 200410247
May 200412285
Jun 200493717
Jul 200418339
Aug 2004162510
Sep 2004122410
Oct 2004194315
Nov 2004123915
Dec 200463410
Jan 2005153421
Feb 200592815
Mar 200591913
Apr 20052229
May 20053258
Jun 20056177
Jul 20056167
Aug 20058215
Sep 200573012
Oct 200562012
Nov 20054226
Dec 200562011
Jan 200682913
Feb 2006492
Mar 20069188
Apr 2006372
May 2006594
Jun 20063134
Jul 2006384
Aug 2006469
Sep 2006387
Oct 20060147
Nov 20063258
Dec 20062122
Jan 20073168
Feb 20075137
Mar 20074167
Apr 20072198
May 20074204
Jun 20073143
Jul 20072167
Aug 2007344
Sep 20075106
Oct 2007101512
Nov 20077137
Dec 20072122
Jan 20083134
Feb 200821920
Mar 2008392
Apr 20089135
May 20089156
Jun 200811258
Jul 200872319
Aug 20087171
Sep 200891312
Oct 200816144
Nov 2008859
Dec 20087111
Jan 20098133
Feb 20091234
Mar 20092093
Apr 20095811
May 200914129
Jun 2009758
Jul 200913126
Aug 2009844
Sep 20091173
Oct 20091362
Nov 2009620
Dec 2009920
Jan 2010773
Feb 20101472
Mar 201024102
Apr 20101726
May 20101453
Jun 20101553
Jul 20102296
Aug 20101242
Sep 20101142
Oct 20101241
Nov 20101695
Dec 2010792
Jan 20111587
Feb 20119104
Mar 20111786
Apr 20111253
May 20111097
Jun 2011856
Jul 201115911
Aug 201151010
Sep 201110149
Oct 201112108
Nov 201117145
Dec 201118710
Jan 201211119
Feb 2012201818
Mar 201213155
Apr 2012181214
May 2012976
Jun 2012569
Jul 2012121510
Aug 20125107
Sep 2012654
Oct 201271610
Nov 20127135
Dec 20122188
Jan 2013172014
Feb 20135118
Mar 20132117
Apr 20135114
May 20133119
Jun 2013065
Jul 20132034
Aug 2013100
Sep 20131044
Oct 2013235
Nov 2013265
Dec 2013432
Jan 20141837
Feb 2014357
Mar 2014358
Apr 20145316
May 20147821
Jun 2014656
Jul 2014643
Aug 2014071
Sep 2014581
Oct 201419143
Nov 2014953
Dec 20147402
Jan 20153574
Feb 20151140
Mar 20151351
Apr 2015552
May 2015774
Jun 2015722
Jul 20157139
Aug 2015643
Sep 2015320
Oct 2015041
Nov 2015736
Dec 2015652
Jan 20163123
Feb 201616141
Mar 20161227
Apr 2016733
May 2016545
Jun 20167101
Jul 2016332
Aug 2016139
Sep 2016463
Oct 20160142
Nov 20162159
Dec 2016065
Jan 20171141
Feb 20170112
Mar 20171112
Apr 2017096
May 2017054
Jun 20170122
Jul 20170121
Aug 20174205
Sep 20170127
Oct 20170141
Nov 20170194
Dec 20170202
Jan 20181120
Feb 2018161
Mar 2018193
Apr 20181182
May 20180113
Jun 2018194
Jul 2018094
Aug 20180146
Sep 20181296
Oct 20180675
Nov 20180667
Dec 201844155
Jan 20196800
Feb 20194500
Mar 20193100
Apr 20191000
May 2019620
Jun 20191222
Jul 2019910
Aug 20191110
Sep 20193111
Oct 20191321
Nov 20192120
Dec 20191610
Jan 20201000
Feb 2020810
Mar 2020710
Apr 2020400
May 20201400
Jun 2020612
Jul 20201211
Aug 2020101
Sep 2020913
Oct 20201500
Nov 2020700
Dec 20203921
Jan 20211340
Feb 20212095
Mar 20211410
Apr 20211021
May 2021651
Jun 2021872
Jul 20211420
Aug 20211360
Sep 2021430
Oct 2021910
Nov 20211910
Dec 2021920
Jan 20221110
Feb 2022710
Mar 20221010
Apr 2022921
May 20221021
Jun 20221200
Jul 20221010
Aug 20222120
Sep 20221131
Oct 2022531
Nov 2022310
Dec 20221121
Jan 20231121
Feb 2023522
Mar 2023732
Apr 2023834
May 2023922

PreviousNext
Back to top

In this issue

Molecular Pharmacology: 61 (5)
Molecular Pharmacology
Vol. 61, Issue 5
1 May 2002
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Reduced Phosphodiesterase 3 Activity and Phosphodiesterase 3A Level in Synthetic Vascular Smooth Muscle Cells: Implications for Use of Phosphodiesterase 3 Inhibitors in Cardiovascular Tissues
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Reduced Phosphodiesterase 3 Activity and Phosphodiesterase 3A Level in Synthetic Vascular Smooth Muscle Cells: Implications for Use of Phosphodiesterase 3 Inhibitors in Cardiovascular Tissues

Heather A. Dunkerley, Douglas G. Tilley, Daniel Palmer, Hanguan Liu, Sandra L. Jimmo and Donald H. Maurice
Molecular Pharmacology May 1, 2002, 61 (5) 1033-1040; DOI: https://doi.org/10.1124/mol.61.5.1033

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Reduced Phosphodiesterase 3 Activity and Phosphodiesterase 3A Level in Synthetic Vascular Smooth Muscle Cells: Implications for Use of Phosphodiesterase 3 Inhibitors in Cardiovascular Tissues

Heather A. Dunkerley, Douglas G. Tilley, Daniel Palmer, Hanguan Liu, Sandra L. Jimmo and Donald H. Maurice
Molecular Pharmacology May 1, 2002, 61 (5) 1033-1040; DOI: https://doi.org/10.1124/mol.61.5.1033
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results and Discussion
    • Acknowledgments
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Cysteine151 in Keap1 Drives CDDO-Me Pharmacodynamic Action
  • Allosteric Modulation of Metabotropic Glutamate Receptor 1
  • Mechanism of Selective Action of Paraherquamide A
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics